Chicken egg white protein ovalbumin (OVA) undergoes a conversion to a more thermostable form by alkali treatment, which is assumed to be involved in the physiological functions of OVA. Ovalbumin-related protein X (OVAX), a chicken egg white protein, has 77% sequence similarity to OVA and binds to heparin. In this study, structure characteristics and heparin-binding affinity of alkali-treated OVAX were investigated. Cation-exchange chromatography using SP Sepharose resin showed that alkali treatment (pH 10, 55
INTRODUCTION
Chicken eggs are an excellent source of protein. Egg white is especially rich in protein, and structures and functionalities of egg white protein have been intensively investigated. Egg white protein possesses various functional properties such as gelling, foaming, emulsifying, protease inhibition, and antimicrobial effect (Burley and Vadehra., 1989; Li-Chan et al., 1995) , so that it is useful as an essential ingredient in food. Therefore, the exploration of the functions of each egg white protein is important for expanding the use of chicken eggs.
Ovalbumin (OVA) is the most abundant protein in chicken egg white, accounting for 54% of egg white protein (Mine, 1995) . During egg storage, OVA undergoes structural transition from native form to a heat-stable form known as stable OVA (S-OVA). The transformation of OVA to S-OVA is assumed to be involved in the biological functions of OVA (Sugimoto et al., C Shinohara et al., 2005) . There exists OVA's paralog, ovalbumin-related protein X (OVAX), of which amino acid sequence shows the high sequence similarity of 77% with OVA (Da Silva et al., 2015) . As with OVA, OVAX belongs to the serine protease inhibitor family (SERPIN), (Stein et al., 1990; Réhault-Godbert et al., 2013) . However, OVAX has no inhibitory activity against the serine protease as OVA does (Réhault-Godbert et al., 2013) . Thus, the physiological functions of OVAX in hen egg at present are still not defined. Recently, Réhault-Godbert et al. (2013) found that OVAX binds to heparin, a highlysulfated polysaccharide. The heparin binding affinity is assumed to be associated with the function of OVAX.
The conversion from native OVA to S-OVA can be reproduced by incubating under hot alkaline condition (alkali treatment) (Smith and Back, 1965; Hatta et al., 2001) . In this study, we investigated whether OVAX undergoes structural changes by alkali treatment. Furthermore, since OVAX, unlike OVA, binds to heparin, heparin binding property of alkali-treated OVAX was investigated to look for clues to elucidate the physiological functions of OVAX.
MATERIALS AND METHODS

Materials
Chicken eggs were purchased from a local farm (Kagawa, Japan). SP Sepharose fast flow beads, Sephacryl TM S-200 high resolution beads, and Heparin Sepharose 6 fast flow beads were obtained from GE Healthcare (Buckinghamshire, England). The ultrafilter, MWCO 10000, was obtained from ADVANTEC (Tokyo, Japan). Protein assay CBB solution (for Bradford method) was obtained from Nacalai Tesque (Kyoto, Japan). All other chemicals were analytical grade.
Purification of OVAX
Hen egg white (120 mL) was mixed with 3-fold volumes of Mili-Q water and adjusted pH 6.0 with 1 N HCl. The resulting precipitate was removed by centrifugation at 8,800 × g for 20 min. The supernatant was loaded into the column packed with SP Sepharose resin (100 mL) equilibrated with 10 mM sodium acetate buffer, pH 6.0. After washing the resin with 200 mL of the same buffer, egg white proteins were first eluted with 400 mL of 10 mM sodium acetate buffer, pH 6.0, followed by with 400 mL of 12.5 mM sodium phosphate buffer (PB), pH 7.5. The remaining binding proteins were eluted with a linear gradient of 0 to 0.5 M NaCl in PB (200 mL each). Lastly, the resin was washed with 150 mL of 0.5 M NaCl in PB. The eluate fractions (5 mL each) were pooled in test tubes. An aliquot 10 μL of each fraction was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using 12.5% acrylamide gel under reducing condition as described by Laemmli (1970) . SDS-PAGE gel was stained with Coomassie Brilliant Blue R-250. Fractions containing a protein with the molecular mass of 45 to 55 kDa were collected and concentrated using an ultra-filter, MWCO 10000. Five milliliters of the concentrated protein solution was loaded into the column packed with Sephacryl S-200 resin (120 mL) equilibrated with PB containing 0.5 M NaCl. The amount of protein in each fraction was detected by absorbance at 280 nm. Molecular masses of proteins in each fraction were determined by SDS-PAGE. Fractions with a single protein band of 50 kDa were collected and dialyzed against deionized water. The dialyzed protein solution was lyophilized and the resulting powder was used as purified OVAX. Protein concentration was determined by Bradford method using bovine serum albumin (BSA) as the standard (Marion, 1976) .
Alkali Treatment
Alkali treatment was conducted as described by Smith and Back (1965) with slight modification. Purified OVAX was dissolved in 0.1 M carbonate buffer, pH 10, to give the concentration of 2.0 mg mL −1 . The OVAX solution was incubated at 55 • C for 6, 12, 18, 24, 51 h and 7 d.
Cation Exchange Chromatography
Alkali-treated OVAX solution was adjusted pH 4.5 with 1 N HCl and applied to the column of SP Sepharose resin (50 mL) which was equilibrated with 10 mM sodium acetate buffer, pH 4.5. After washing with 200 mL of the same buffer, proteins were eluted with 125 mL of PB, pH 7.5, followed by with 100 mL of 0.5 M NaCl in PB, pH 7.5. The eluate fractions (5 mL each) were pooled in test tubes. The amount of protein in each fraction was detected by absorbance at 280 nm and Bradford method. Molecular masses of proteins were checked by SDS-PAGE.
Zeta Potential Measurement
Three mg protein was dissolved in 2 mL of 10 mM PB, pH 7.0. The protein solution was put in a rectangular quartz standard cell and electrophoretic mobility of these solutions in the cell was measured with a zeta potential analyzer (Zeta-Potential & Particle Size Analyzer ELSZ-2000 G; Otsuka Electronics, Tokyo, Japan). The zeta potential was calculated from the electrophoretic mobility using the software (version 3.60 / 2.30) provided from the manufacturer (Otsuka Electronics, Tokyo, Japan). The data were recorded in triplicate.
Tryptophan Fluorescence Measurement
Tryptophan fluorescence spectrum of protein was measured with a fluorescence spectrophotometer (FP-6200; JASCO Corporation, Tokyo, Japan). Protein solution at a concentration of 0.2 mg/mL in 10 mM PB, pH 7.0 was put in a fluorescence quartz cuvette with 4 clear windows and the fluorescent spectrum of protein excited at 295 nm was measured at 25
• C in the emission range of 300 to 400 nm.
Circular Dichroism Measurement
Circular dichroism (CD) measurement was made with a CD spectropolarimeter (J-1100; JASCO Corp.). Protein solution at a concentration of 0.1 mg/mL in 10 mM PB, pH 7.0 was put in a 1-mm path-length quartz cuvette and the CD spectrum of protein was measured in the range of 190 to 260 nm. Four scans of spectra (scan rate of 20 nm/min, a response time of 4 s and a band width of 1 nm) were averaged and the CD signals (ellipticity) obtained were converted to molar ellipticity using protein concentration and a mean amino acid residue weight of 113 g/mol for OVAX. The CD spectrum in molar ellipticity was analyzed by the JWMVS-529 Multivariate SSE analysis program provided from the manufacturer, to estimate the secondary structure content of protein.
Heparin Binding Capacity
Heparin binding capacity was evaluated by determining NaCl concentration required for elution from Heparin Sepharose 6 Fast Flow. Purified native OVAX and acidic OVAX, and alkali-treated OVAX (a mixture of native and acidic OVAX) were dialyzed against 10 mM Tris-HCl, pH 7.4. After dialysis, each sample was applied to the column of Heparin Sepharose resin (50 mL), which was equilibrated with 10 mM Tris-HCl, pH 7.4. After washing with 100 mL of the same buffer, proteins were eluted with a linear NaCl gradient of 0 to 1.0 M in 10 mM Tris-HCl, pH 7.4 (100 mL each).
RESULTS
Electric Property of Native OVAX
Egg white separated from fresh eggs was separated by cation exchange chromatography using SP Sepharose resin, followed by gel filtration chromatography using Sephacryl S-200 resin. In SP Sepharose chromatogram, 2 major proteins, corresponding to molecular mass of 14 and 50 kDa, were eluted with a NaCl gradient at pH7.5 ( Figure 1A, B) . The 14 kDa protein is a basic protein lysozyme (Lyz). The 50 kDa protein was identified as OVAX by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry/mass spectrometry (MALDI-TOF-MS/MS) analysis (consistency with fragments calculated from protein sequence of accession number, gi:971382511, data not shown). The fact that OVAX with theoretical isoelectric point (pI) 6.29 elutes in fractions close to Lyz suggests that OVAX at pH 7.5 has a basic domain on its molecular surface which interacts strongly with negatively-charged sulfonic acid groups on SP Sepharose resin. Gel filtration chromatogram shows the success of purification of OVAX ( Figure 1C ).
Electric Property of Alkali-Treated OVAX
Alkali treatment of OVAX was assessed by incubating purified OVAX in 0.1 M carbonate buffer (pH 10) at 55
• C. OVAX solution was incubated for 12 h under the alkaline condition followed by SP Sepharose column chromatography. The chromatogram of the alkalitreated OVAX showed 2 peaks (Figure 2A, B) . The first peak was eluted by changing pH from 4.5 to 7.5 and the second peak was eluted with 0.5 M NaCl at pH 7.5. The elution profile of the second peak was identical to that of untreated native OVAX. Thus, the first peak newly emerged because of the alkali treatment. Molecular mass of a protein of the first peak was 50 kDa, suggesting that it is not a degradant of OVAX due to alkali treatment. This result suggests that alkali treatment of OVAX induces a distinct conformational state of OVAX that has different surface charge distribution from native OVAX. The net surface charge of the 2 proteins recovered from the 2 peaks was measured by zeta potential analyses at pH 7.0. Zeta potential value of the second peak protein (native OVAX) was -5.2 mV, while that of the first peak protein (an atypical OVAX) was -11.9 mV, indicating that the molecular surface of the atypical OVAX is more acidic than native OVAX. These results suggest that the net surface charge of OVAX is changed to more acidic form by alkali treatment, and thereby the protein contained in the first peak of the SP Sepharose chromatogram was named acidic OVAX.
The time course of the formation of acidic OVAX during the alkali treatment is shown in Figure 2C . The result displayed a time-dependent increase in the ratio of acidic OVAX. The conversion rate to acidic OVAX reached as much as 80% after 7 d incubation.
Structural Properties of Alkali-Treated OVAX
Structural properties of purified acidic OVAX were investigated by analyzing its intrinsic tryptophan fluorescence. The intrinsic tryptophan fluorescence spectrum of acidic OVAX was very similar to that of native OVAX ( Figure 3A) , suggesting that the surrounding environment of tryptophan residues is similar between native OVAX and acidic OVAX. To further explore structural features of the acidic OVAX, its secondary structure was determined by far-UV circular dichroism (CD) spectroscopy. Acidic OVAX displayed a significantly different CD spectrum from native OVAX (Figure 3B) . Table 1 shows the result of secondary structure prediction of acidic OVAX. Alpha-helical content of acidic OVAX was as much as 8% lower than that of native OVAX. Thus, it was evident that the global tertiary structure is not greatly affected (based on Trp fluorescence data), but unfolding of even a small helix necessarily changes the local protein structure. 
Heparin Binding Ability
To determine whether alkali treatment affects the heparin binding ability of OVAX, native and acidic OVAX were applied to Heparin Sepharose column. Heparin binding ability was evaluated by NaCl concentration required for releasing protein from Heparin Sepharose resin ( Figure 4A, B. ). Native OVAX eluted from the resin at the high NaCl concentration of 730 mM, whereas acidic OVAX eluted at 325 mM NaCl. OVAX alkali-treated for 51 h was also examined ( Figure 4C ). The alkali-treated OVAX exhibited 2 peaks eluting at 285 mM and 685 mM NaCl, respectively, suggesting that the first peak is acidic OVAX and the second peak is native OVAX. Consequently, acidic OVAX exhibits weaker interactions with Heparin Sepharose resin than native OVAX does.
DISCUSSION
Structural Properties of OVAX
Although OVAX belongs to the SERPIN family, OVAX does not show any protease inhibitory activity (Réhault-Godbert et al., 2013) . Réhault-Godbert et al. (2013) reported that OVAX exerts antimicrobial effects against Listeria monocytogenes and Salmonella enteritidis. However, the antimicrobial effects are not stronger than that of other antimicrobial egg white proteins, including Lyz (Guyot et al., 2016a (Guyot et al., , 2016b Proctor et al., 1988; Renata and Grzegorz, 2008; Mine et al., 2004) , cystatin (Wesierska et al., 2005) , and ovotransferrin (Valenti et al., 1982; Babini and Livermore, 2000) , and the antimicrobial spectrum is not as broad as for those egg white proteins. If OVAX does not function in the egg as host protection against bacterial infection, then the physiological function of OVAX is even less clear than previously thought.
OVAX has 77% similarity in amino acid sequence with OVA. Nevertheless, OVA in sodium phosphate buffer (pH7.5) did not bind to SP Sepharose resin, while OVAX in the same buffer did ( Figure 1B) , suggesting that electrical properties on the molecular surface of protein differs between OVAX and OVA. OVAX appears to have behaved like a basic protein in the interaction with the cation-exchange resin. A theoretical pI value of OVAX calculated from amino acid sequence is 6.29. Furthermore, the zeta potential analysis of OVAX showed that the net surface charge of OVAX at neutral pH (7.0) is negative. Despite these facts, the basic-protein-like behavior on the cation-exchange resin suggests the existence of a specific binding site for the negative charge, positive charge cluster (a basic cluster), on OVAX surface, which coincides with Réhault-Godbert's findings (Da Silva et al., 2015; Réhault-Godbert et al., 2013) . According to Réhault-Godbert et al. (2013) , the cluster including positive charges corresponds to the sixty one amino acid residues from S 78 to K 138 of the OVAX sequence. We constructed a 3 dimensional structure of OVAX by homology-modeling using OVA structure (PDB ID: 1OVA) as a template ( Figure 5 ). Although tertiary structure of OVAX model was fairly similar to that of OVA (the r.m.s.d. = 0.3Å for all atoms), a cluster of basic amino acid residues, the basic cluster, at the molecular surface was found only in OVAX. The result that OVAX has the basic cluster supports the Réhault-Godbert's findings. We speculate that the existence of the basic cluster domain made OVAX possible to specifically bind to the cationexchange resin, SP Sepharose, though ionic bonds. Comparison of homology-modeled OVAX 3D-structure with OVA 3D-structure. X-ray crystal structure of OVA (PDB ID: 1OVA) is shown in (A). Homology-modeled OVAX structure was built on SWISS-MODEL homology modeling server using the OVA structure (PDB ID: 1OVA) as a template. Basic amino acids (Arg, Lys) are indicated in black. The dashed circle highlights the OVAX basic cluster. Tryptophan residues are displayed with arrows.
Structural Properties of Alkali-Treated OVAX
Alkali treatment produced the atypical OVAX. The atypical OVAX emerged in earlier elution peak of the SP Sepharose chromatogram (Figure 2A, B) . The emergence of the single peak represents that alkali treatment induces a 2-state structural transition of OVAX, rather than stepwise structural transitions. The atypical OVAX emerged by alkali treatment did not bind to SP Sepharose resin at pH 7.5, while native OVAX bound to the resin. The significant difference in binding affinity to the negative charge of the resin is consistent with the result of zeta potential analysis, showing that the atypical OVAX displays more negative charges on its molecular surface than native OVAX does. Furthermore, the proportion of the atypical OVAX which was named acidic OVAX increased with alkali treatment time. Thus, it was evident that the chemical conversion from native form to acidic form proceeds timedependently. We also analyzed the structural change of OVAX by heat (55
• C) treatment alone (at not pH 10.0, but pH 6.0). The heat treatment alone (55
• C and pH 6.0) caused protein aggregation of OVAX (data not shown), which is totally different behavior from the formation of acidic OVAX induced by the alkali-treatment.
Therefore, it is suggested that both of heating (55
• C) and alkali condition (pH 10.0) participate in the production of acidic OVAX.
CD and tryptophane-fluorescence analyses showed that acidic OVAX has an 8% lower α-helical content than native counterpart, while the spatial localization of Trp residues of acidic OVAX is similar to that of native OVAX. These results suggest that there exists a relation between the acidification of the OVAX surface charge and the decrease of α-helical content. OVAX has four Trp residues, of which 3 residues (W 199 , W 282 and W 400 ) are located at distances of 30 to 40Å from the basic cluster (located on the opposite side of the basic cluster) and one residue (W 163 ) is at distance of 12Å or longer (see Figure 5) . The relatively large geometric distances between the Trp residues and the basic cluster are consistent with that a local conformational change of the basic cluster does not affect Trpfluorescence spectrum of OVAX. Alpha-helix of OVAX basic cluster is estimated to account for 7% of the constructed OVAX 3D structure from the secondary structure assignment. Assuming that basic cluster domain of OVAX is the ligand binding site of negative charges of SP Sepharose resin, the 8% loss of OVAX α-helix without any change in Trp-fluorescence spectrum suggests that the decrease in binding affinity of OVAX to SP Sepharose resin is due to the dispersion of positive charges taking place during the unfolding of α-helical basic cluster. Hence, we propose that alkali treatment induces the unfolding of OVAX basic cluster, resulting in weakening the interaction with SP Sepharose resin.
Heparin Binding Property of Alkali-Treated OVAX
Heparin is a negatively charged glycosaminoglycan secreted from mastocytes (Lindahl et al., 1986) and is present in the extracellular matrix. Heparin is viewed as potential therapeutics for a variety of diseases. OVAX has been reported to bind to Heparin Sepharose resin (Da Silva et al., 2015; Réhault-Godbert et al., 2013; Itoh et al., 1993) . The heparin binding site of OVAX is assumed to be the basic cluster (Da Silva et al., 2015; Réhault-Godbert et al., 2013) . The present study showed that alkali treatment of OVAX results in the decrease in binding affinity to Heparin Sepharose resin. The reduction in the affinity is due to the conformational transition of OVAX from native form to acidic form. As confirmed by the CD and Trp-fluorescence spectra, the conformational change of OVAX arises mainly in its basic cluster part. Accordingly, we think that the affinity reduction is due to disorganization of OVAX basic cluster domain. Réhault-Godbert et al. (2013) reported that both OVA and OVAX have consensus sequence of heparin binding proteins (X-B-B-X-B-X, where X is a hydropathic residue, and B is a basic residue. Cardin and Weintraub, 1989) , ERKIKV (277-280) for OVA, and KRRVKV (290-294) for OVAX.
Despite the fact that OVA has the consensus sequence, OVA had no heparin-binding ability (data not shown). Réhault-Godbert et al. (2013) presumed that the heparin binding site of OVAX is not the consensus site but the basic cluster protruding from the molecular surface. Our finding that the decrease in heparin binding ability of OVAX by alkali treatment is due to the conformational change of the basic cluster strongly supports their presumption that basic cluster is the heparin-binding site of OVAX. Five Lys residues are located in 2 α-helical segments (P 86 -K 90 and P 120 -L 129 ) in the basic cluster. Positive charges of the 5 Lys residues may be interacting with negative charges of heparin, such as sulfate groups.
Alkali treatment converts OVA to a heat-stable form known as S-OVA. S-OVA is incorporated into chicken embryo and may be involved in a dynamic function in developing organs in particular at the central nervous system in the embryogenesis (Sugimoto et al., 1999; Shinohara et al., 2005) . In contrast, OVAX is converted to acidic OVAX where its basic cluster undergoes a conformational change. It seems likely that OVAX basic cluster is a specific ligand of heparin that participates in numerous biological functions by interacting with hormones and proteins. During the process of egg hatching, OVAX may undergo a conformational change similar to that induced by alkali treatment and which may result in a decreased binding affinity of OVAX for heparin similar to that observed for acidic OVAX. Such a decrease in the binding affinity for heparin during hatching may enable OVAX to participate in the regulation of heparin functions that include anticoagulant activity (Höök et al., 1976; Jin et al., 1997) , angiogenesis (Chiodelli et al., 2015; Muñoz and Linhardt, 2004) and cell proliferation in vivo (Rapraeger et al., 1991; Le and Musil, 2001) . Functional studies on OVAX will be reported in next papers.
The present study investigated structural changes of OVAX by alkali treatment, because structural changes of OVA by alkali treatment appear to relate to some physiological functions. If structural change of OVAX to its acidic form occurs in egg hatching process, it may regulate the functions of heparin. In vivo studies on native OVAX and acidic OVAX using sperm eggs are needed to better elucidate biological functions of OVAX in chicken egg. The findings may provide information for designing new heparin-inspired drugs and enhance the industrial utilization of egg proteins.
